固体和强烈的低频是一系列的阿霉素脂质体的基本特征。
Solid and strong low frequency is the basic characteristic of LADM series.
目的探讨应用微波辐射联合阿霉素脂质体对兔v X 2肝肿瘤的治疗作用。
Objective To assess the therapeutic effect of microwave radiation combined with Adriamycin liposome on liver VX2 tumor in rabbits.
用该方法对阿霉素脂质体样品中的微量硫酸根离子进行了分析测定，结果令人满意。
This method has been proved to be simple, sensitive and accurate, and also has been applied to determine sulfate ion in liposome doxorubicin sample with satisfactory results.
目的：制备盐酸表阿霉素脂质体，建立HPLC含量测定方法并优选包封率测定方法。
Objectives: To prepare epirubicin hydrochloride liposomes(Epi-lip), establish an HPLC method for the determination of EPI and to optimize the method for determination of entrapment efficiency(EE%).
本文主要研究了制备包封率在80%以上的盐酸阿霉素脂质体注射液，并具有一定的稳定性。
This paper mainly studies the preparation encapsulation efficiency in more than 80% of hydrochloric acid doxorubicin liposomes injection, and has certain stability.
结果表明，靶向脂质体组阿霉素（ADM）在肿瘤组织的含量明显高于游离阿霉素组。
The results indicated that the content of ADM target liposomes in the tumor tissues was higher apparently than free ADM.
通过观察脂质体-阿霉素系统(PLD)在舌癌模型的外周血及颈淋巴结内的药物浓度，探讨PLD治疗舌癌的价值。
To observe the concentration of Pegylated Liposmal Doxorubicin (PLD) in tongue cancer model, and to evaluate the value of PLD in the therapy of oral cancer.
结论：磁性阿霉素隐形脂质体作为一种新型抗肿瘤药物显示了良好的应用前景。
Conclusion: Magnetic doxorubicin stealth liposome, regarding as a new kind carrier of anti-tumor drug, indicated a favorable foreground.
结论磁性阿霉素隐形脂质体作为一种新型抗肿瘤药物显示了良好的应用前景。
Conclusion Magnetic doxorubicin stealth liposome as a new anti-tumor drug carrier may have a favorable clinical prospect.
目的：观察脂质体阿霉素对大鼠三叉神经形态与功能的影响。
Objective: To observe the effects of liposome adriamycin on the morphology and function of trigeminal nerve in rats.
目的：研究磁性阿霉素隐形脂质体对裸鼠移植性人胃癌的疗效。
Objective: To study on the curative effect of magnetic doxorubicin stealth liposome in human gastric cancer xenografts in nude mice.
目的探讨磁性阿霉素隐形脂质体靶向治疗裸鼠移植性人胃癌的疗效。
Objective To study the effect of magnetic doxorubicin stealth liposome on human gastric cancer xenografts in nude mice.
目的利用包裹阿霉素的血管内皮生长因子（VEGF）脂质体于体外靶向杀伤肿瘤血管内皮细胞。
ObjectiveTo evaluate the targeting ability and cytotoxicity of adriamycin liposomes conjugated with VEGF in vitro.
目的比较阿霉素隐形脂质体与普通脂质体的抗肿瘤活性。
OBJECTIVE To compare the antitumor activity between stealth liposomal doxorubicin and regular liposomal doxorubicin.
向细胞靶向递送脂质体抗癌药物阿霉素可以在体外获得更好的疗效。
The targeted delivery of liposomal anticancer drug doxorubicin results in better therapeutic efficacy towards cells in vitro.
结论：脂质体载药后可降低阿霉素的毒性并保留药物的抗肿瘤活性。
CONCLUSION: The liposome agent could reduce toxicities and remain its antitumor effect of adriamycin.
与阿霉素普通脂质体相比，提高了对生长抑素受体表达阳性的NCIH- 446细胞的毒性及其阿霉素摄取量。
Compared to plain doxorubicin liposome, octreotide-grafted doxorubicin liposome showed stronger cytotoxicity and higher cellular uptake on NCI H-446 expressing somatostatin receptor.
与阿霉素普通脂质体相比，提高了对生长抑素受体表达阳性的NCIH- 446细胞的毒性及其阿霉素摄取量。
Compared to plain doxorubicin liposome, octreotide-targeting doxorubicin liposome showed stronger cytotoxicity and higher cellular uptake on NCI H-446 expressing somatostatin receptor.
与阿霉素普通脂质体相比，提高了对生长抑素受体表达阳性的NCIH- 446细胞的毒性及其阿霉素摄取量。
Compared to plain doxorubicin liposome, octreotide-targeting doxorubicin liposome showed stronger cytotoxicity and higher cellular uptake on NCI H-446 expressing somatostatin receptor.
应用推荐